We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+9.83%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+557.96%
AUM
$91.9B
AUM Growth
-$622M
Cap. Flow
-$6.86B
Cap. Flow %
-7.46%
Top 10 Hldgs %
34.23%
Holding
7,315
New
572
Increased
2,784
Reduced
3,105
Closed
393

Sector Composition

Rank Sector Weight
1 Technology 5.74%
2 Healthcare 5.25%
3 Financials 4.26%
4 Communication Services 3.9%
5 Consumer Discretionary 3.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AXE
2276
DELISTED
Anixter International Inc
AXE
$1.6M ﹤0.01%
20,211
+19,740
+4,191% +$1.61M
RARE icon
2277
Ultragenyx Pharmaceutical
RARE
$2.55B
$1.6M ﹤0.01%
23,585
+18,282
+345% +$1.39M
CB icon
2278
CALL
Chubb
CB
$135B
$1.59M ﹤0.01%
11,700
-100
-0.8% -$13.4K
TS icon
2279
Tenaris
TS
$26.8B
$1.59M ﹤0.01%
46,492
+28,994
+166% +$987K
EXEL icon
2280
CALL
Exelixis
EXEL
$13.4B
$1.58M ﹤0.01%
72,900
-18,800
-21% -$382K
MDCO
2281
CALL
DELISTED
Medicines Co
MDCO
$1.58M ﹤0.01%
+32,300
New +$1.47M
BPOP icon
2282
Popular Inc
BPOP
$11.1B
$1.58M ﹤0.01%
38,733
+28,866
+293% +$1.24M
CX icon
2283
CALL
Cemex
CX
$16.3B
$1.58M ﹤0.01%
181,110
+83,616
+86% +$703K
HUBB icon
2284
Hubbell
HUBB
$27.2B
$1.58M ﹤0.01%
13,156
+8,814
+203% +$1.06M
PAAS icon
2285
Pan American Silver
PAAS
$21.6B
$1.57M ﹤0.01%
89,796
+38,237
+74% +$695K
DMC
2286
Del Monte Corp
DMC
$1.45B
$1.57M ﹤0.01%
26,550
+22,446
+547% +$1.32M
SBS icon
2287
Sabesp
SBS
$18.7B
$1.57M ﹤0.01%
778,929
+40,092
+5% +$79.1K
TVTY
2288
DELISTED
Tivity Health, Inc. Common Stock
TVTY
$1.57M ﹤0.01%
54,030
+22,040
+69% +$581K
WPZ
2289
CALL
DELISTED
Williams Partners L.P.
WPZ
$1.57M ﹤0.01%
38,400
-7,600
-17% -$306K
YELP icon
2290
CALL
Yelp
YELP
$1.41B
$1.56M ﹤0.01%
47,800
-223,500
-82% -$8.29M
ASNA
2291
DELISTED
Ascena Retail Group, Inc.
ASNA
$1.56M ﹤0.01%
18,356
+15,748
+604% +$1.51M
EMN icon
2292
PUT
Eastman Chemical
EMN
$8.42B
$1.56M ﹤0.01%
19,300
-24,900
-56% -$1.96M
BHP icon
2293
PUT
BHP
BHP
$230B
$1.56M ﹤0.01%
48,091
-700,513
-94% -$24.2M
PHM icon
2294
PUT
Pultegroup
PHM
$25.3B
$1.56M ﹤0.01%
66,100
-37,900
-36% -$816K
FGP
2295
DELISTED
Ferrellgas Partners, L.P.
FGP
$1.55M ﹤0.01%
258,724
+43,918
+20% +$305K
EBIX
2296
DELISTED
Ebix Inc
EBIX
$1.55M ﹤0.01%
25,364
+21,631
+579% +$1.29M
RRD
2297
DELISTED
RR Donnelley & Sons Co.
RRD
$1.55M ﹤0.01%
127,878
+91,962
+256% +$1.47M
PAAS icon
2298
PUT
Pan American Silver
PAAS
$21.6B
$1.55M ﹤0.01%
88,300
+21,900
+33% +$398K
FLOW
2299
DELISTED
SPX FLOW, Inc.
FLOW
$1.55M ﹤0.01%
44,581
+22,832
+105% +$780K
TM icon
2300
PUT
Toyota
TM
$225B
$1.54M ﹤0.01%
14,200
-14,200
-50% -$1.63M

Similar funds

Barclays's Q1 2017 Portfolio in Review

As of Q1 2017, Barclays held 7,315 positions worth $91.9B, down 0.67% from $92.5B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Barclays withdrew a net $6.86B in Q1 2017, closing 393 positions and reducing 3,105 holdings. Its most notable exit was St Jude Medical, an estimated $235M position sold in full.

By sector, the portfolio is most concentrated in Technology at 5.7% of assets, up from 4.7% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Barclays opened a new position in iPath S&P VEQTOR ETN worth $95.8M.

  • Barclays's largest Q1 2017 buy was iPath S&P VEQTOR ETN: 670,000 shares worth $95.8M.
  • Barclays added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q1 2017, an estimated $1.04B increase.
  • Barclays's biggest Q1 2017 reduction was TotalEnergies, cutting an estimated $427M.
  • Barclays fully exited St Jude Medical in Q1 2017, selling an estimated $235M.
  • Barclays's ten largest holdings make up 34% of its $91.9B portfolio in Q1 2017.
  • Barclays opened 572 new positions and closed 393 in Q1 2017.
  • Barclays's portfolio value fell 0.67% quarter-over-quarter to $91.9B.

Based on Barclays's 13F filing for Q1 2017, filed 15 May 2017.